Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pitx2
|
ENSMUSG00000028023.10 | paired-like homeodomain transcription factor 2 |
Otx2
|
ENSMUSG00000021848.9 | orthodenticle homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_48665732_48667167 | Otx2 | 928 | 0.343300 | -0.32 | 1.3e-02 | Click! |
chr14_48658827_48658978 | Otx2 | 3030 | 0.121753 | -0.31 | 1.4e-02 | Click! |
chr14_48661734_48663217 | Otx2 | 397 | 0.705913 | -0.30 | 2.2e-02 | Click! |
chr14_48663565_48664293 | Otx2 | 1057 | 0.311863 | -0.28 | 2.8e-02 | Click! |
chr14_48661065_48661235 | Otx2 | 782 | 0.429132 | -0.27 | 3.7e-02 | Click! |
chr3_129151217_129151368 | Pitx2 | 48586 | 0.122891 | 0.36 | 4.5e-03 | Click! |
chr3_129215238_129216443 | Pitx2 | 1565 | 0.337791 | 0.35 | 6.8e-03 | Click! |
chr3_129216664_129219042 | Pitx2 | 3578 | 0.195954 | 0.35 | 6.8e-03 | Click! |
chr3_129213621_129215189 | Pitx2 | 130 | 0.953665 | 0.18 | 1.7e-01 | Click! |
chr3_129202581_129205165 | Pitx2 | 74 | 0.968903 | -0.14 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_133700764_133701966 | 10.24 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr16_32611646_32611832 | 10.01 |
Tfrc |
transferrin receptor |
2489 |
0.22 |
chr11_6527341_6527511 | 8.80 |
Snhg15 |
small nucleolar RNA host gene 15 |
333 |
0.64 |
chr18_54423477_54423649 | 8.37 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
1268 |
0.55 |
chr4_46401911_46402304 | 7.77 |
Hemgn |
hemogen |
2129 |
0.22 |
chr4_123285872_123286357 | 7.62 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3019 |
0.13 |
chr4_115059803_115061295 | 7.25 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
1041 |
0.47 |
chr5_134913335_134913584 | 7.23 |
Cldn13 |
claudin 13 |
2067 |
0.15 |
chr5_103755393_103755691 | 6.89 |
Aff1 |
AF4/FMR2 family, member 1 |
969 |
0.6 |
chr6_113691496_113691649 | 6.88 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
827 |
0.33 |
chr19_38123347_38124097 | 6.78 |
Rbp4 |
retinol binding protein 4, plasma |
1003 |
0.47 |
chr9_120116040_120116439 | 6.76 |
Slc25a38 |
solute carrier family 25, member 38 |
1250 |
0.23 |
chr6_146220976_146221548 | 6.69 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
6281 |
0.26 |
chr4_134865800_134866096 | 6.53 |
Rhd |
Rh blood group, D antigen |
1412 |
0.38 |
chr15_103258192_103259041 | 6.52 |
Nfe2 |
nuclear factor, erythroid derived 2 |
213 |
0.88 |
chr3_127916475_127916802 | 6.48 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
466 |
0.76 |
chr8_105824819_105825076 | 6.35 |
Ranbp10 |
RAN binding protein 10 |
2258 |
0.14 |
chr6_38346220_38346504 | 6.35 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
7911 |
0.13 |
chr8_94984127_94985009 | 6.22 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
98 |
0.95 |
chr12_57195355_57195515 | 6.17 |
Slc25a21 |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 |
2037 |
0.35 |
chr6_88897317_88897924 | 5.97 |
Mcm2 |
minichromosome maintenance complex component 2 |
1057 |
0.36 |
chr3_103130913_103131239 | 5.97 |
Dennd2c |
DENN/MADD domain containing 2C |
3520 |
0.16 |
chr13_51648489_51648653 | 5.85 |
Gm22806 |
predicted gene, 22806 |
372 |
0.83 |
chr14_32165229_32167031 | 5.84 |
Ncoa4 |
nuclear receptor coactivator 4 |
9 |
0.96 |
chr7_45523041_45524800 | 5.80 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr7_4629257_4630354 | 5.69 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr4_46401482_46401633 | 5.68 |
Hemgn |
hemogen |
2679 |
0.19 |
chr3_14888603_14889051 | 5.54 |
Car2 |
carbonic anhydrase 2 |
2188 |
0.31 |
chr9_44338857_44339185 | 5.53 |
Hmbs |
hydroxymethylbilane synthase |
510 |
0.48 |
chr17_29657345_29657508 | 5.50 |
Gm20161 |
predicted gene, 20161 |
910 |
0.41 |
chr14_121145029_121145811 | 5.44 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
43341 |
0.18 |
chr6_128889970_128890562 | 5.38 |
BC035044 |
cDNA sequence BC035044 |
858 |
0.36 |
chr2_71874985_71875555 | 5.27 |
Pdk1 |
pyruvate dehydrogenase kinase, isoenzyme 1 |
191 |
0.95 |
chr8_23035959_23037041 | 5.26 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr7_103812474_103812838 | 5.20 |
Hbb-bt |
hemoglobin, beta adult t chain |
1340 |
0.18 |
chr15_100668768_100669476 | 5.19 |
Bin2 |
bridging integrator 2 |
383 |
0.73 |
chrX_150550146_150550715 | 5.16 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
2971 |
0.19 |
chr2_157130956_157131109 | 5.15 |
Samhd1 |
SAM domain and HD domain, 1 |
975 |
0.49 |
chr7_90133863_90134130 | 5.15 |
Gm45223 |
predicted gene 45223 |
1504 |
0.24 |
chr9_21289620_21289771 | 5.11 |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
1458 |
0.2 |
chr2_104098689_104099469 | 5.01 |
Cd59a |
CD59a antigen |
3239 |
0.16 |
chr5_74062697_74063380 | 4.92 |
Usp46 |
ubiquitin specific peptidase 46 |
2710 |
0.15 |
chr15_36647605_36647897 | 4.91 |
Gm6704 |
predicted gene 6704 |
17882 |
0.12 |
chr11_117781529_117781854 | 4.77 |
Tmc8 |
transmembrane channel-like gene family 8 |
385 |
0.5 |
chr9_44340100_44340251 | 4.75 |
Hmbs |
hydroxymethylbilane synthase |
459 |
0.53 |
chr19_6448363_6449146 | 4.75 |
Nrxn2 |
neurexin II |
2456 |
0.17 |
chr14_66999338_66999780 | 4.74 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
98 |
0.96 |
chr15_74933225_74933498 | 4.72 |
Gm39556 |
predicted gene, 39556 |
3924 |
0.11 |
chr2_24977509_24977697 | 4.72 |
Pnpla7 |
patatin-like phospholipase domain containing 7 |
1455 |
0.19 |
chr4_115057577_115059724 | 4.63 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr10_75939108_75939976 | 4.59 |
Gm867 |
predicted gene 867 |
1069 |
0.25 |
chr16_92824962_92826063 | 4.59 |
Runx1 |
runt related transcription factor 1 |
266 |
0.94 |
chr9_21029266_21030734 | 4.58 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr14_121365539_121365809 | 4.57 |
Stk24 |
serine/threonine kinase 24 |
5806 |
0.22 |
chr12_111442182_111444685 | 4.56 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr12_57195678_57195869 | 4.56 |
Slc25a21 |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 |
1699 |
0.39 |
chr6_136855871_136856717 | 4.47 |
Art4 |
ADP-ribosyltransferase 4 |
1439 |
0.23 |
chr11_98909522_98909960 | 4.46 |
Cdc6 |
cell division cycle 6 |
1590 |
0.24 |
chr6_38553565_38553735 | 4.41 |
Luc7l2 |
LUC7-like 2 (S. cerevisiae) |
1807 |
0.28 |
chr5_137569837_137570642 | 4.39 |
Tfr2 |
transferrin receptor 2 |
370 |
0.67 |
chr8_105299573_105299747 | 4.38 |
E2f4 |
E2F transcription factor 4 |
1943 |
0.11 |
chr11_4224297_4224597 | 4.38 |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
6222 |
0.1 |
chr11_115899671_115901427 | 4.32 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr17_48271543_48271790 | 4.31 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
773 |
0.51 |
chr14_63124817_63125155 | 4.27 |
Ctsb |
cathepsin B |
2472 |
0.2 |
chr7_19290671_19291896 | 4.27 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr10_80434279_80434455 | 4.24 |
Tcf3 |
transcription factor 3 |
720 |
0.46 |
chr19_31870559_31871023 | 4.23 |
A1cf |
APOBEC1 complementation factor |
2010 |
0.39 |
chr3_103172753_103173085 | 4.22 |
Bcas2 |
breast carcinoma amplified sequence 2 |
1134 |
0.38 |
chr16_32508454_32509173 | 4.17 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
9202 |
0.13 |
chr9_114730694_114730845 | 4.13 |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
347 |
0.86 |
chr15_98829829_98830195 | 4.11 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
959 |
0.33 |
chr13_96698342_96698685 | 4.11 |
Gm48575 |
predicted gene, 48575 |
20390 |
0.14 |
chr3_88338560_88338725 | 4.11 |
Smg5 |
Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) |
2078 |
0.12 |
chr1_131135705_131136011 | 4.07 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
2387 |
0.21 |
chr4_130295752_130296038 | 4.01 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
12700 |
0.13 |
chr1_15806540_15806733 | 3.99 |
Terf1 |
telomeric repeat binding factor 1 |
972 |
0.54 |
chr13_22022235_22022395 | 3.99 |
Gm11292 |
predicted gene 11292 |
4384 |
0.06 |
chr12_76256073_76256502 | 3.97 |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
807 |
0.38 |
chr7_79661914_79662687 | 3.97 |
Ticrr |
TOPBP1-interacting checkpoint and replication regulator |
2053 |
0.21 |
chr11_83850990_83852424 | 3.96 |
Hnf1b |
HNF1 homeobox B |
535 |
0.69 |
chr11_85137850_85138212 | 3.96 |
Usp32 |
ubiquitin specific peptidase 32 |
1898 |
0.25 |
chrX_137118132_137120673 | 3.96 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr6_146579499_146579843 | 3.94 |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
1729 |
0.26 |
chr8_13106885_13107036 | 3.92 |
Cul4a |
cullin 4A |
1024 |
0.31 |
chr4_117829636_117830257 | 3.90 |
Gm12842 |
predicted gene 12842 |
4290 |
0.13 |
chr4_117181699_117181956 | 3.88 |
Kif2c |
kinesin family member 2C |
715 |
0.38 |
chr11_86681779_86681934 | 3.87 |
Vmp1 |
vacuole membrane protein 1 |
1965 |
0.25 |
chr11_106997509_106997660 | 3.85 |
Kpna2 |
karyopherin (importin) alpha 2 |
903 |
0.48 |
chr9_48336275_48336541 | 3.84 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
4426 |
0.24 |
chr6_117909988_117910250 | 3.82 |
4933440N22Rik |
RIKEN cDNA 4933440N22 gene |
2359 |
0.16 |
chr7_38105884_38106218 | 3.79 |
Ccne1 |
cyclin E1 |
857 |
0.57 |
chr2_144267097_144267273 | 3.77 |
Snord17 |
small nucleolar RNA, C/D box 17 |
969 |
0.35 |
chr8_117200247_117200873 | 3.77 |
Gan |
giant axonal neuropathy |
42423 |
0.14 |
chr6_135167280_135167635 | 3.76 |
Hebp1 |
heme binding protein 1 |
678 |
0.55 |
chr19_43888532_43890580 | 3.72 |
Dnmbp |
dynamin binding protein |
1135 |
0.42 |
chr14_32167230_32167769 | 3.72 |
Ncoa4 |
nuclear receptor coactivator 4 |
1378 |
0.28 |
chr8_80495549_80496014 | 3.71 |
Gypa |
glycophorin A |
2000 |
0.38 |
chr16_38374654_38375717 | 3.70 |
Popdc2 |
popeye domain containing 2 |
3187 |
0.17 |
chr15_3271737_3272448 | 3.67 |
Selenop |
selenoprotein P |
7 |
0.98 |
chr13_113858981_113859647 | 3.66 |
Arl15 |
ADP-ribosylation factor-like 15 |
64692 |
0.1 |
chr5_90491061_90491214 | 3.64 |
Afp |
alpha fetoprotein |
101 |
0.96 |
chr12_79611853_79612048 | 3.64 |
Rad51b |
RAD51 paralog B |
284597 |
0.01 |
chr5_121206249_121206443 | 3.62 |
Rpl6 |
ribosomal protein L6 |
292 |
0.82 |
chr3_153908033_153909893 | 3.60 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chr4_124605630_124606127 | 3.59 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
36688 |
0.11 |
chr18_10028053_10028243 | 3.58 |
Usp14 |
ubiquitin specific peptidase 14 |
1874 |
0.32 |
chr7_127014020_127014913 | 3.58 |
Mvp |
major vault protein |
84 |
0.88 |
chr19_56289015_56289491 | 3.57 |
Habp2 |
hyaluronic acid binding protein 2 |
1257 |
0.48 |
chr11_83281871_83282887 | 3.57 |
Slfn14 |
schlafen 14 |
4347 |
0.1 |
chr3_102165384_102165916 | 3.57 |
Vangl1 |
VANGL planar cell polarity 1 |
290 |
0.87 |
chr5_23921352_23921520 | 3.55 |
Fam126a |
family with sequence similarity 126, member A |
1468 |
0.33 |
chr13_23501510_23501892 | 3.55 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
12844 |
0.06 |
chr14_24493256_24494729 | 3.54 |
Rps24 |
ribosomal protein S24 |
2843 |
0.22 |
chr2_71203657_71204120 | 3.51 |
Dync1i2 |
dynein cytoplasmic 1 intermediate chain 2 |
7818 |
0.23 |
chr15_78571734_78572724 | 3.51 |
Rac2 |
Rac family small GTPase 2 |
552 |
0.62 |
chr6_142471604_142471923 | 3.47 |
Gys2 |
glycogen synthase 2 |
1346 |
0.42 |
chr6_67161407_67161578 | 3.46 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3432 |
0.2 |
chr11_73135048_73135217 | 3.46 |
Haspin |
histone H3 associated protein kinase |
3162 |
0.16 |
chr9_57298978_57299129 | 3.45 |
Gm18996 |
predicted gene, 18996 |
30362 |
0.12 |
chr9_40323395_40324376 | 3.45 |
1700110K17Rik |
RIKEN cDNA 1700110K17 gene |
459 |
0.71 |
chr5_139253993_139254144 | 3.45 |
Get4 |
golgi to ER traffic protein 4 |
557 |
0.69 |
chr5_74064229_74066220 | 3.44 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr16_45952627_45953612 | 3.42 |
Phldb2 |
pleckstrin homology like domain, family B, member 2 |
374 |
0.84 |
chr13_22039834_22040858 | 3.41 |
H4c9 |
H4 clustered histone 9 |
1016 |
0.18 |
chr15_64310595_64311230 | 3.41 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
777 |
0.63 |
chr16_23102639_23103369 | 3.40 |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
4440 |
0.07 |
chr2_25546036_25546265 | 3.39 |
Traf2 |
TNF receptor-associated factor 2 |
760 |
0.35 |
chr12_84150828_84152588 | 3.38 |
Pnma1 |
paraneoplastic antigen MA1 |
3219 |
0.13 |
chr11_102363631_102364272 | 3.37 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
247 |
0.85 |
chr12_33966605_33968831 | 3.37 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
10047 |
0.22 |
chr18_12170260_12170696 | 3.37 |
Rmc1 |
regulator of MON1-CCZ1 |
1726 |
0.26 |
chr13_109690436_109691162 | 3.36 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
4623 |
0.36 |
chr2_181241290_181242534 | 3.35 |
Helz2 |
helicase with zinc finger 2, transcriptional coactivator |
51 |
0.95 |
chr1_75217265_75217807 | 3.34 |
Tuba4a |
tubulin, alpha 4A |
102 |
0.89 |
chr8_22806758_22806919 | 3.32 |
1700041G16Rik |
RIKEN cDNA 1700041G16 gene |
1072 |
0.34 |
chr4_123286559_123286710 | 3.31 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3539 |
0.12 |
chr3_88364024_88365387 | 3.31 |
Paqr6 |
progestin and adipoQ receptor family member VI |
112 |
0.89 |
chr7_80296357_80296607 | 3.30 |
Prc1 |
protein regulator of cytokinesis 1 |
1969 |
0.18 |
chr11_95778449_95778609 | 3.30 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
17038 |
0.11 |
chr18_68228785_68229512 | 3.30 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
1081 |
0.51 |
chr12_76708834_76709007 | 3.29 |
Sptb |
spectrin beta, erythrocytic |
1103 |
0.52 |
chr19_32180563_32180876 | 3.28 |
Sgms1 |
sphingomyelin synthase 1 |
15709 |
0.21 |
chr2_170154555_170154763 | 3.27 |
Zfp217 |
zinc finger protein 217 |
6556 |
0.3 |
chr13_23537141_23537479 | 3.27 |
H3c8 |
H3 clustered histone 8 |
1888 |
0.09 |
chr11_30984934_30985367 | 3.26 |
Chac2 |
ChaC, cation transport regulator 2 |
1184 |
0.43 |
chr1_64738076_64739059 | 3.26 |
Fzd5 |
frizzled class receptor 5 |
816 |
0.55 |
chr19_8943915_8944549 | 3.26 |
Mta2 |
metastasis-associated gene family, member 2 |
198 |
0.82 |
chr5_103756323_103756745 | 3.25 |
Aff1 |
AF4/FMR2 family, member 1 |
1961 |
0.36 |
chr11_84827522_84827949 | 3.24 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
1229 |
0.28 |
chrX_101528203_101528437 | 3.23 |
Taf1 |
TATA-box binding protein associated factor 1 |
4414 |
0.18 |
chr8_121088119_121090419 | 3.23 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr19_29068022_29068464 | 3.22 |
Gm9895 |
predicted gene 9895 |
896 |
0.45 |
chr13_41236642_41237224 | 3.21 |
Gm32063 |
predicted gene, 32063 |
588 |
0.6 |
chr1_127773096_127773421 | 3.20 |
2900009J06Rik |
RIKEN cDNA 2900009J06 gene |
796 |
0.43 |
chr17_25089311_25089630 | 3.19 |
Ift140 |
intraflagellar transport 140 |
1201 |
0.31 |
chr17_29493756_29495031 | 3.19 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr6_135196879_135197189 | 3.18 |
Fam234b |
family with sequence similarity 234, member B |
943 |
0.32 |
chr11_62005417_62006894 | 3.18 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
805 |
0.61 |
chr6_83247659_83247969 | 3.16 |
Slc4a5 |
solute carrier family 4, sodium bicarbonate cotransporter, member 5 |
10439 |
0.12 |
chr7_4629049_4629207 | 3.14 |
Tmem86b |
transmembrane protein 86B |
1059 |
0.25 |
chr10_91169483_91169746 | 3.14 |
Tmpo |
thymopoietin |
848 |
0.58 |
chr7_110773542_110774597 | 3.14 |
Ampd3 |
adenosine monophosphate deaminase 3 |
175 |
0.93 |
chr10_59873887_59874700 | 3.13 |
Gm7413 |
predicted gene 7413 |
2611 |
0.21 |
chr15_103253562_103255772 | 3.13 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr10_78007045_78007518 | 3.12 |
Pfkl |
phosphofructokinase, liver, B-type |
2446 |
0.17 |
chr11_95355520_95356805 | 3.11 |
Fam117a |
family with sequence similarity 117, member A |
16200 |
0.11 |
chr13_23536389_23536737 | 3.11 |
H3c8 |
H3 clustered histone 8 |
1141 |
0.16 |
chr1_184728502_184729126 | 3.10 |
Hlx |
H2.0-like homeobox |
2784 |
0.2 |
chr10_120363772_120364466 | 3.10 |
1700006J14Rik |
RIKEN cDNA 1700006J14 gene |
38 |
0.97 |
chr4_43498521_43499110 | 3.10 |
Arhgef39 |
Rho guanine nucleotide exchange factor (GEF) 39 |
260 |
0.79 |
chr12_106027314_106027536 | 3.10 |
Vrk1 |
vaccinia related kinase 1 |
1618 |
0.43 |
chr11_85340610_85340853 | 3.08 |
Bcas3 |
breast carcinoma amplified sequence 3 |
12436 |
0.2 |
chr19_12573120_12574715 | 3.08 |
Fam111a |
family with sequence similarity 111, member A |
394 |
0.72 |
chr17_27825976_27826687 | 3.07 |
Ilrun |
inflammation and lipid regulator with UBA-like and NBR1-like domains |
5683 |
0.13 |
chr9_31253741_31253909 | 3.07 |
Gm7244 |
predicted gene 7244 |
20996 |
0.14 |
chr7_100465236_100467118 | 3.06 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr11_117059965_117061040 | 3.05 |
Gm11731 |
predicted gene 11731 |
2077 |
0.18 |
chr2_34913220_34914094 | 3.04 |
Phf19 |
PHD finger protein 19 |
319 |
0.7 |
chr13_34340668_34341142 | 3.04 |
Slc22a23 |
solute carrier family 22, member 23 |
3298 |
0.23 |
chr7_105751423_105752172 | 3.04 |
Tpp1 |
tripeptidyl peptidase I |
295 |
0.79 |
chr16_91804661_91805209 | 3.03 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
299 |
0.9 |
chr1_149960340_149960517 | 3.02 |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
827 |
0.68 |
chr14_76532606_76533942 | 3.02 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr1_185459944_185460584 | 3.02 |
Gm2061 |
predicted gene 2061 |
4696 |
0.14 |
chr13_22041691_22041998 | 3.02 |
H4c9 |
H4 clustered histone 9 |
482 |
0.34 |
chr7_118126848_118127762 | 3.00 |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
1805 |
0.29 |
chr7_19462776_19463744 | 3.00 |
Exoc3l2 |
exocyst complex component 3-like 2 |
71 |
0.92 |
chr11_6527621_6527833 | 2.98 |
Snhg15 |
small nucleolar RNA host gene 15 |
32 |
0.85 |
chr8_70630408_70630616 | 2.97 |
Gdf15 |
growth differentiation factor 15 |
1583 |
0.19 |
chr4_132342884_132343681 | 2.97 |
Rcc1 |
regulator of chromosome condensation 1 |
2075 |
0.11 |
chr11_121436757_121437039 | 2.97 |
Fn3k |
fructosamine 3 kinase |
1930 |
0.23 |
chr3_95753977_95754134 | 2.96 |
Tars2 |
threonyl-tRNA synthetase 2, mitochondrial (putative) |
300 |
0.8 |
chr3_122247672_122247837 | 2.96 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
1673 |
0.2 |
chr14_69276807_69277225 | 2.95 |
Gm20236 |
predicted gene, 20236 |
5124 |
0.1 |
chr13_107063721_107063872 | 2.95 |
Gm31452 |
predicted gene, 31452 |
101 |
0.96 |
chr5_139734507_139735058 | 2.95 |
Micall2 |
MICAL-like 2 |
1554 |
0.31 |
chr17_57010152_57010303 | 2.94 |
Gtf2f1 |
general transcription factor IIF, polypeptide 1 |
1061 |
0.23 |
chr2_154890638_154890946 | 2.94 |
Eif2s2 |
eukaryotic translation initiation factor 2, subunit 2 (beta) |
1990 |
0.35 |
chr14_63123716_63123867 | 2.93 |
Ctsb |
cathepsin B |
1277 |
0.35 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.4 | 7.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.3 | 14.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.9 | 5.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.9 | 1.9 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.8 | 5.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.7 | 5.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 5.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.6 | 6.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.6 | 38.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.5 | 4.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.5 | 4.4 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.4 | 5.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.4 | 4.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 1.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.3 | 5.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.3 | 5.0 | GO:0032264 | IMP salvage(GO:0032264) |
1.2 | 3.7 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.2 | 6.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.2 | 6.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
1.2 | 3.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.2 | 5.9 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.2 | 2.4 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.2 | 3.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.1 | 3.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.1 | 3.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.1 | 1.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.1 | 5.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.1 | 3.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 5.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 3.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.0 | 4.2 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.0 | 3.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 1.0 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
1.0 | 9.0 | GO:0070269 | pyroptosis(GO:0070269) |
1.0 | 3.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.0 | 2.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 2.9 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
1.0 | 2.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 7.6 | GO:0097286 | iron ion import(GO:0097286) |
0.9 | 2.8 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.9 | 4.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.9 | 2.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 2.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.9 | 5.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.9 | 0.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.9 | 0.9 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.9 | 2.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 3.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 4.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 4.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.9 | 3.5 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.9 | 3.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 2.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 11.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.9 | 2.6 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.9 | 2.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.9 | 0.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.8 | 2.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.8 | 3.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 1.7 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.8 | 3.3 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.8 | 2.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.8 | 2.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 0.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.8 | 2.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.8 | 3.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 2.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 2.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 2.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 0.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.8 | 2.3 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.8 | 5.4 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.8 | 1.5 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.8 | 2.3 | GO:0008228 | opsonization(GO:0008228) |
0.8 | 9.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 0.8 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 4.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.7 | 3.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 3.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 0.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.7 | 2.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 6.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.7 | 2.1 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.7 | 2.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 1.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.7 | 2.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 4.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 1.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.7 | 2.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 2.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.7 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 2.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 2.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 2.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.6 | 1.9 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 1.9 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.6 | 1.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 2.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 3.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.6 | 1.9 | GO:0061010 | gall bladder development(GO:0061010) |
0.6 | 1.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 15.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 2.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.6 | 1.9 | GO:0045472 | response to ether(GO:0045472) |
0.6 | 5.5 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 0.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 0.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.6 | 1.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 2.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 0.6 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.6 | 2.4 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.6 | 1.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 3.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.6 | 4.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.6 | 0.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.6 | 0.6 | GO:0006848 | pyruvate transport(GO:0006848) |
0.6 | 1.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.6 | 1.8 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 1.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.6 | 2.3 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.6 | 1.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.6 | 1.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 2.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.6 | 1.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.6 | 7.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 2.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 1.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.6 | 1.7 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 4.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 3.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 1.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.6 | 3.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 2.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 2.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 3.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.6 | 1.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 2.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.6 | 3.3 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 1.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.5 | 3.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.5 | 1.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 1.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.5 | 4.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 3.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.5 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 5.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 0.5 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 2.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.5 | 1.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.0 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.5 | 2.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 6.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 1.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 2.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 3.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.5 | 2.5 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.5 | 4.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.5 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 1.5 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 1.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.5 | 1.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.5 | 6.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.5 | 1.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.5 | 0.5 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.5 | 4.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 4.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 0.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.5 | 3.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 0.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.5 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 3.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 5.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.5 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 7.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 2.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 2.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 6.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 1.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 1.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.5 | 1.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.4 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.5 | 2.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 1.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 5.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 0.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 1.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 1.9 | GO:0046618 | drug export(GO:0046618) |
0.5 | 0.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 0.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 0.9 | GO:0007127 | meiosis I(GO:0007127) |
0.5 | 1.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 0.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 2.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 1.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 1.4 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.4 | 1.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 0.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 0.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 1.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 0.9 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.4 | 4.0 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.4 | 2.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 0.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 4.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 1.8 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.4 | 3.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 1.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 1.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 2.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 0.4 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.4 | 2.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 2.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.4 | 1.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.9 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.4 | 0.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.4 | 1.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.4 | 0.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 0.8 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.4 | 0.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 2.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 0.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 2.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 3.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.8 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.4 | 1.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.4 | 0.8 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 2.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 0.4 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.4 | 0.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 1.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 2.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 0.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 2.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 7.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 1.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.4 | 3.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 0.4 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 2.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 1.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 3.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 2.0 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.4 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 5.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 5.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 4.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 1.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 2.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.4 | 1.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 0.8 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.4 | 1.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.4 | 2.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 1.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.4 | 3.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 1.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 3.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.4 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.4 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 1.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 2.6 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 7.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 2.6 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 1.5 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.4 | 1.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 1.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 0.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.4 | 1.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 0.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.4 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.4 | 3.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 2.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 0.7 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.4 | 0.4 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.4 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 1.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 9.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 1.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 1.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 3.2 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.7 | GO:0046113 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) nucleobase catabolic process(GO:0046113) |
0.4 | 1.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 3.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 1.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 0.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 0.4 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 1.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 2.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 0.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.3 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.3 | 2.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.7 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 4.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 2.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 1.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 2.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 1.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.3 | 1.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.3 | 3.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 2.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 0.3 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.3 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 1.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 3.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 1.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 0.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 0.7 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 0.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.3 | 0.3 | GO:0051054 | positive regulation of DNA metabolic process(GO:0051054) |
0.3 | 5.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 1.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 3.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 5.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 1.0 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.3 | 2.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 1.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.3 | 1.0 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 6.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.9 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 1.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 0.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 0.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.3 | 1.9 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 1.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 1.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 1.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:0010985 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
0.3 | 1.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 6.8 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.3 | 0.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 3.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 2.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.8 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 2.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.6 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.3 | 1.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.6 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.3 | 1.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 5.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.6 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 1.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 0.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.6 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.3 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 0.6 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.3 | 0.9 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 0.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 3.8 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.3 | 0.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.3 | 0.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.6 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.8 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.3 | 2.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 4.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.8 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 1.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 1.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 3.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 2.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.4 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.3 | 1.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 2.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.3 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.3 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 1.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
0.3 | 1.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.8 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.3 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.5 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 0.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 0.5 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.3 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 1.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.3 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.8 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.3 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.3 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 2.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 3.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 2.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.5 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 1.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.8 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.3 | 4.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 4.8 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.3 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 2.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.3 | 4.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.7 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 0.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 1.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 2.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 2.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 2.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 3.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 2.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 2.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 1.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.7 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 2.6 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.2 | 0.2 | GO:0048289 | negative regulation of isotype switching(GO:0045829) isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 1.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 1.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.7 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 2.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 1.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 3.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 1.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 2.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.4 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 1.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 2.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.7 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 3.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.9 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 2.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.2 | 0.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 0.4 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.7 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.2 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.7 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.2 | 1.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 2.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.2 | 0.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.6 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.2 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 1.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.2 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.8 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 3.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.6 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 0.6 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 3.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 1.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 1.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.2 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 3.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.2 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 1.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.6 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 2.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.8 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 0.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 2.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 2.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 1.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.8 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 1.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 2.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 5.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 2.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.2 | 1.0 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 2.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 1.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 1.1 | GO:0033048 | negative regulation of mitotic sister chromatid segregation(GO:0033048) |
0.2 | 0.6 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.2 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.2 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 0.4 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 0.6 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 2.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.7 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 0.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.4 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 3.4 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 3.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 2.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.2 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 4.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 1.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 8.1 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 1.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 6.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 2.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 6.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 1.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.4 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 1.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 3.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.7 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.2 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 9.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 1.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 3.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.5 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 4.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 1.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 1.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.5 | GO:0003174 | mitral valve development(GO:0003174) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 2.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 2.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 1.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 6.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 2.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.3 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.2 | 2.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.7 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 6.2 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 3.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 0.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.2 | 1.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.2 | 2.7 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.2 | 0.9 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.4 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 0.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 2.5 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.2 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 1.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 7.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.8 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.8 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.2 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 3.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.2 | 1.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.2 | 1.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 1.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.4 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 2.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 1.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.9 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 1.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 1.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 1.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 1.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.7 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.7 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.1 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 2.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.7 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.5 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.1 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 4.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.5 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 1.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 1.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.8 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 2.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 1.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 3.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 2.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 1.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 1.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.1 | 0.4 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 1.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 1.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.1 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.6 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 1.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.1 | 2.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 1.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 1.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.1 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.3 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 5.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 1.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.9 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 2.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 3.5 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.4 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 1.5 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.1 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 2.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 16.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 1.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 1.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 1.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.2 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.1 | 1.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 2.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 2.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 1.0 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.1 | 1.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.2 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.8 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.1 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.3 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.7 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 1.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0045141 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere clustering(GO:0045141) |
0.1 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.1 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 1.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 1.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0033087 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 6.3 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.6 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0046952 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 1.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 1.7 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.1 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.5 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.0 | GO:0006533 | fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.6 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.0 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.3 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 6.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.1 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.4 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.6 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.0 | GO:0071221 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0002891 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 1.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.6 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.0 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.1 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.3 | GO:0006757 | ATP generation from ADP(GO:0006757) |
0.0 | 2.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:1903902 | positive regulation of viral life cycle(GO:1903902) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.1 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.8 | 10.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 8.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.8 | 5.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.6 | 8.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 7.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 3.4 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 3.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.0 | 3.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.0 | 3.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.9 | 2.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 2.7 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 3.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.9 | 3.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.8 | 3.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 3.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.8 | 2.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.8 | 3.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 3.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.8 | 4.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.7 | 2.2 | GO:0000811 | GINS complex(GO:0000811) |
0.7 | 7.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 2.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 7.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.7 | 4.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 2.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 2.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 5.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.6 | 1.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 11.2 | GO:0002102 | podosome(GO:0002102) |
0.6 | 2.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 1.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.6 | 2.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 2.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 3.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 2.8 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 9.0 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 3.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 3.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 1.7 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 4.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 2.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 1.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 2.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 6.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 2.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 1.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 3.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 3.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.5 | 3.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 5.0 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 2.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 2.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 1.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.5 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 17.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 1.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.7 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 3.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 0.4 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.4 | 2.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 2.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 9.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 1.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 24.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 2.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 2.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 2.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 3.2 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.6 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 2.4 | GO:0005818 | aster(GO:0005818) |
0.4 | 5.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 3.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 2.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 2.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 1.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 10.0 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 1.8 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 4.3 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 1.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 22.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 2.4 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 2.0 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 2.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 5.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 2.3 | GO:0070187 | telosome(GO:0070187) |
0.3 | 5.2 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 2.9 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 2.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 2.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 1.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 12.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 12.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 1.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.5 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.3 | 3.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 2.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 8.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 3.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 0.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 3.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 1.1 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 1.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 2.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 0.3 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.3 | 11.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 10.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 2.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.5 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 7.1 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 3.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 2.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 4.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 2.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 10.2 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 10.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.7 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 2.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 2.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 6.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 20.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 5.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 3.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 3.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 4.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 2.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 10.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 1.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 2.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 5.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 3.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 12.9 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 15.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 2.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 61.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 5.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 8.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 2.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 2.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 7.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 9.1 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.6 | GO:0036379 | myofilament(GO:0036379) |
0.2 | 1.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 2.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 12.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 3.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 3.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.5 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 2.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 4.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 7.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 2.0 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 16.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 3.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.1 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.1 | 1.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 5.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 5.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 3.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 2.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 9.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 2.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 3.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 2.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 34.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 5.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 4.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 19.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 3.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 3.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 1.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 5.3 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.7 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 7.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 3.1 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 7.0 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 63.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 2.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 54.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 12.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 4.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.2 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 1.8 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 35.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 2.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.6 | 4.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.6 | 4.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.6 | 6.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.3 | 5.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 3.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.1 | 4.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.1 | 4.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.1 | 4.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 3.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.0 | 3.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 3.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 2.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.0 | 2.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.0 | 2.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.0 | 3.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 3.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.9 | 3.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 3.7 | GO:0015265 | urea channel activity(GO:0015265) |
0.9 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 2.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.9 | 2.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 6.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.9 | 3.4 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 2.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 2.5 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.8 | 4.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.8 | 4.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 5.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.7 | 3.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 4.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 5.8 | GO:0052668 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.7 | 2.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 14.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.7 | 4.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 1.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.7 | 2.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 3.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.7 | 4.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 2.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 3.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.7 | 2.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 2.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 2.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 2.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 1.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 1.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 2.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 2.5 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.6 | 4.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 2.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.6 | 3.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 1.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 5.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.6 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 2.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 3.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.6 | 4.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.6 | 3.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 2.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 1.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 1.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 2.2 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 2.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 4.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 1.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 1.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 7.7 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 3.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 1.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 2.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.5 | 1.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 8.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 1.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 2.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 2.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 2.4 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.5 | 3.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 0.5 | GO:0032142 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.5 | 1.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 2.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 1.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 2.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 0.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.5 | 2.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 1.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 3.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 1.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 0.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 3.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 21.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 8.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 0.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 5.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 0.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.4 | 1.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 2.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 2.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 0.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 1.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 5.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 4.8 | GO:0043176 | amine binding(GO:0043176) |
0.4 | 1.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 1.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 3.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 1.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 1.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 12.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 1.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 7.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 10.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 1.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 1.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 1.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 3.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 1.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 5.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 1.7 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 2.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 1.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 2.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 4.0 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 5.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 3.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 4.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 1.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 3.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 3.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 2.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.3 | 2.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.7 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 0.3 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.3 | 1.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.6 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 8.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 2.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 2.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.3 | 1.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 4.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 5.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 2.5 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 2.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 1.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 1.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 6.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 11.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 4.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 3.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.9 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 2.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 1.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 5.2 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 2.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 0.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 4.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 3.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 2.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 5.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 4.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 2.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 8.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 5.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 2.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 3.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 1.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 2.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 3.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 6.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.3 | 3.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.3 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) NAD-dependent protein deacetylase activity(GO:0034979) |
0.3 | 10.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 7.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 7.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 1.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 3.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 1.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 6.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 7.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 2.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 8.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 8.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 4.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 1.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 3.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 1.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 3.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.7 | GO:0034893 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.2 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 4.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 3.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 1.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 2.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.2 | GO:0097617 | annealing activity(GO:0097617) |
0.2 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 6.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 1.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 35.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 1.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 2.1 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 3.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 2.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 12.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 4.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 7.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 1.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 3.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 2.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 3.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 8.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 4.1 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 3.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 1.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 1.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 6.3 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 1.9 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 1.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 11.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 3.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 0.5 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 2.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 1.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 1.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 3.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 2.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.2 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 6.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.3 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 3.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 1.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 4.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 1.5 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 2.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 2.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 6.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 2.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 1.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.0 | GO:0018657 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 2.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 3.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 3.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 1.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 3.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) type 2A serotonin receptor binding(GO:0031826) |
0.1 | 4.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 2.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 1.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 3.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 16.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 12.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 5.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 4.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 2.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 3.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 1.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.8 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 3.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 4.5 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 2.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.1 | 1.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.2 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 1.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 2.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 5.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 3.2 | GO:0060090 | binding, bridging(GO:0060090) |
0.1 | 1.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 2.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 4.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 3.5 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 3.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 10.1 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0016160 | amylase activity(GO:0016160) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 3.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 1.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 2.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.7 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 9.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 4.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 2.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 1.6 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 27.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.8 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 1.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.4 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 4.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.0 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 1.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 1.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 3.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 4.5 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 2.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 4.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 2.5 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.3 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.6 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.0 | 0.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 2.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 5.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 5.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 19.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 11.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 16.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 1.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 22.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 5.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 4.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 1.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 11.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 7.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 17.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 18.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 0.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 21.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 3.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 5.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 6.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 13.3 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 5.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 4.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 4.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 9.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 15.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 4.2 | PID ATM PATHWAY | ATM pathway |
0.3 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 10.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 7.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 2.6 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 7.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 1.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 9.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 8.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 6.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 7.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 9.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 2.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 3.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 14.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 2.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 3.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 2.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 1.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 7.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 3.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 4.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 4.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 3.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 12.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 26.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 12.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 8.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.9 | 15.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.7 | 4.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.7 | 8.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 1.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 10.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 6.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 5.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 4.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 5.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 4.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 7.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 1.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 5.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 12.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 4.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.5 | 2.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 5.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 5.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 10.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 3.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 7.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 15.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 1.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 3.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 36.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.4 | 1.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 0.4 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.4 | 24.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 9.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 4.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 4.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 5.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 3.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 3.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 7.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 4.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 30.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 8.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 2.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 5.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 6.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 5.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 33.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 6.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 5.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 5.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.3 | 1.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 3.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 3.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 5.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 8.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 1.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 6.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 1.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 3.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 6.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 6.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 0.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 4.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 4.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 1.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 3.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 2.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 2.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 10.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 8.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 12.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 21.8 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.3 | 3.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 0.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 4.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 2.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 8.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 6.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 5.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 3.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 3.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 1.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 2.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 0.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 6.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 4.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 2.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 6.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 6.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 16.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 3.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 2.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 5.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 7.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 1.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 4.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 4.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 1.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 2.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.8 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 3.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 5.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 2.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 10.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 11.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 5.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 1.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.4 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |